What is the best brand of nattokinase to buy?

Two nattokinase capsules can both read "100 mg" on the front of the bottle and deliver completely different amounts of active enzyme.

That gap is not a marketing quibble. The industry's own standards body warns that some products carry FU labels higher than their actual measured activity [6], and that some sold as nattokinase contain no nattokinase at all. If you are new to the enzyme itself, our complete guide to nattokinase covers the mechanism and the evidence base in full.

So the best brand of nattokinase is not a name. It is six specifications you can check on any label in about two minutes.

Table of Contents

1. Why There Is No Single Best Brand of Nattokinase
2. Fibrinolytic Units: The One Number That Decides Everything
3. What Dose Does the Research Actually Support?
4. Vitamin K2: Why Its Absence Is a Specification
5. Capsule Delivery: Whether the Dose Actually Arrives
6. Verification: Testing, Certification and Licensing
7. The Two-Minute Label Check
8. BioAbsorb Nattokinase Enzyme Against the Six Criteria
9. Frequently Asked Questions
10. Conclusion

1. Why There Is No Single Best Brand of Nattokinase

Nattokinase has no consumer-facing ranking authority. The closest thing is the Japan NattoKinase Association, whose membership covers only a fraction of the brands selling nattokinase worldwide — and which exists in part because counterfeit and under-potency products entered the market [6].

Reputation is also a weaker signal than most shoppers assume. FDA inspection data obtained under freedom-of-information request showed that in fiscal 2023, 78 inspections — close to 33% of firms receiving a Form 483 — were cited for failing to establish product specifications [10], with a further 18% cited on ingredient identity specifications alone.

That is why this guide does not name a winner. Six verifiable specifications do more work than any brand ranking, and each one takes under 20 seconds to check on a label or product page.

2. Fibrinolytic Units: The One Number That Decides Everything

A fibrinolytic unit (FU) measures what the enzyme does, not what it weighs. Clinical monographs record that nattokinase activity is expressed in fibrinolytic units and that the enzyme is inactive in acidic conditions [11]. Commercial products are generally standardised at around 2,000 FU per 100 mg, but that ratio depends on enzyme purity and manufacturing process — which is exactly why two 100 mg capsules are not interchangeable.

The Japan NattoKinase Association sets 2,000 FU as the standard daily dosage requirement and requires FU-based potency labelling on certified products. It also warns explicitly that some products state FU values higher than their measured activity [6], and that a subset contain other enzymes entirely, with no confirmed safety profile.

The practical rule is short:

• FU should appear on the front label, not only milligrams.
• 2,000 FU is the reference daily amount, not a maximum.
• A milligram-only label gives you no way to compare 2 products.
• Products advertising 20,000 FU per gram of raw material are describing the ingredient, not your capsule.

3. What Dose Does the Research Actually Support?

The most cited human trial randomised 86 adults with untreated systolic pressure of 130–159 mmHg to 2,000 FU daily or placebo for 8 weeks. Compared with control, systolic pressure fell by 5.55 mmHg and diastolic by 2.84 mmHg [1], with 73 participants completing the protocol.

Pooling the evidence moderates that picture. A 2023 systematic review rated as high methodological quality found across 6 randomised trials and 546 participants that nattokinase reduced systolic pressure by 3.45 mmHg and diastolic by 2.32 mmHg [2] versus placebo. These are meaningful but modest numbers, not drug-scale effects. Our review of nattokinase and heart health works through what these figures mean in cardiovascular terms.

Higher doses have been studied, with caveats. A study of 1,062 participants taking 10,800 FU daily for 12 months [3] reported improved lipid profiles and slowed atherosclerosis progression, and its authors argued the 2,000 FU recommendation is too low — but that study was retrospective and observational, not randomised, so it carries less weight than the 6 controlled trials above. For a full breakdown of how the dose ladder works in practice, see our nattokinase dosage guide.

4. Vitamin K2: Why Its Absence Is a Specification

Natto, the fermented soybean food nattokinase comes from, is one of the richest known dietary sources of vitamin K2. Clinical references note that vitamin K2 may be removed from nattokinase supplements during manufacturing [11], and that the same monograph advises avoiding nattokinase in ischemic stroke, peptic ulcer, coagulation disorders, and in the period around surgery.

This matters most for 1 specific group. Warfarin works by antagonising vitamin K, so residual K2 in an unpurified extract works against the medication — while the enzyme itself may add to bleeding risk. Anyone on an anticoagulant needs physician supervision before taking nattokinase at any dose, regardless of the K2 status on the label. We cover the distinction between the two compounds in detail in are K2 and nattokinase the same?

A label that states K2 status explicitly is telling you the manufacturer performed a purification step and tested for it. BioAbsorb's nattokinase is formulated free of vitamin K2, which also leaves readers already supplementing K2 separately free to dose it independently.

5. Capsule Delivery: Whether the Dose Actually Arrives

Nattokinase is a protein, and proteins are vulnerable to stomach acid. Formulation research places gastric pH at 1–3 against small intestine pH of 6–7.5 [5], and sets the gastro-resistance benchmark at no more than 10% release in acid over at least 2 hours.

This is why delivery format is a specification and not a detail. Clinical monographs record that microencapsulated and enteric-coated formulations were developed specifically to reduce gastric degradation [11] of the enzyme — a step a plain capsule does not take. A 2,000 FU label on a plain capsule is a starting quantity, not a delivered one.

Delayed-release capsule shells achieve the same goal by a different route: the shell itself holds contents through the stomach rather than relying on an added coating. BioAbsorb uses DRcaps delayed-release veggie capsules, which avoid the phthalates and plasticizers used in some conventional enteric coatings. Our article on nattokinase and circulation looks at what happens once the enzyme reaches the bloodstream.

6. Verification: Testing, Certification and Licensing

Certification is only useful when it involves an outside party. The JNKA mark cannot be self-applied: a product must be submitted to the association and pass its examination [7] against defined criteria before the mark may appear on packaging. A brand's own quality statement carries less weight than 1 external audit.

Regulatory status differs sharply by country, and it is worth knowing which market you are buying from. In Canada, every natural health product requires a product licence with an 8-digit Natural Product Number before it can be sold [8], and manufacturing sites need a separate site licence with GMP compliance. The United States has no equivalent pre-market approval step.

That said, a licence number is not proof a product works. Roughly 90,000 such licences have been granted since 2004 [9], and one can be issued without any human clinical trial evidence of efficacy — it speaks to contamination screening and safety, not results. Batch-level third-party testing for enzyme activity, heavy metals and microbial contaminants is the more informative signal.

7. The Two-Minute Label Check

Every criterion above collapses into 6 questions. If a product page cannot answer 4 of the 6, that absence is itself the answer — and it takes under 2 minutes to run through.

• FU stated? Look for a fibrinolytic unit figure, not just a milligram weight.
• How many FU per capsule? 2,000 FU is the reference amount used in most controlled trials.
• Vitamin K2 status stated? Silence usually means it was never tested for.
• Capsule format? Delayed-release or enteric, versus a plain shell.
• Third-party tested, per batch? Activity, heavy metals and microbials — all 3, not just 1.
• Where is it manufactured, and under what licence? Regulatory regimes differ between the 2 North American markets.

Price only becomes meaningful after those 6 are answered. A cheaper bottle with no FU figure is not cheaper, because the quantity you are comparing is undefined — and the association's own counterfeit warning exists precisely because that undefined quantity is sometimes zero. Cost per day at a stated FU level is the only fair comparison.

BioAbsorb Nattokinase Enzyme Against the Six Criteria

Applying the same 6 checks to BioAbsorb's Nattokinase Enzyme: potency is stated in FU at 2,000 FU per 100 mg capsule, matching the dose used in the 8-week randomised trial discussed above. The formulation is free of vitamin K2, so it does not introduce the vitamin into the diet of anyone managing K2 intake deliberately.

Delivery uses DRcaps delayed-release veggie capsules rather than a conventional enteric coating, avoiding the phthalates and plasticizers found in some coated formats. Every batch is third-party tested on 4 fronts — nattokinase activity at 2,000 FU or above per capsule, heavy metals, gluten, and microbial contaminants — which addresses the identity and potency specification failures that FDA inspectors cite most often.

Manufacturing is Canadian, in a GMP-certified, non-irradiated facility. The formulation is non-GMO and free of gluten, nuts, eggs, dairy, fish, shellfish and all animal products. The 180-capsule bottle at $49.87 works out to roughly $0.28 per day, taken as 1 capsule daily on an empty stomach.

What it does not claim matters too: no bioavailability percentage is asserted, because no head-to-head absorption trial exists for this format. That is a limit of the category, not a feature of any 1 brand.

Frequently Asked Questions

Is a higher FU number always better?

Not necessarily. The strongest randomised evidence sits at 2,000 FU daily, and a controlled crossover study in healthy men found that a single 2,000 FU dose measurably improved peripheral blood flow [4]. Doses above that have mostly been tested in observational rather than randomised settings.

Does "100 mg nattokinase" mean the same as 2,000 FU?

Roughly, but not reliably. The working conversion is about 2,000 FU per 100 mg, though the ratio shifts with enzyme purity and manufacturing method, so 2 products at the same milligram weight can differ in activity. If a label gives milligrams only, treat the potency as unknown.

Should I choose a vitamin K2-free nattokinase?

It depends on your situation. If you take warfarin or already supplement K2 separately, a K2-free formulation removes 1 variable from the equation; if neither applies, K2 content is not a drawback. Either way, anyone on an anticoagulant should speak to their physician before starting nattokinase.

Does third-party testing mean the FU claim is verified?

Only if the testing covers enzyme activity specifically. Many supplement test panels check heavy metals and microbials but not potency — and potency is the one the Japan NattoKinase Association’s counterfeit warning is directly concerned with. Look for activity testing named explicitly.

Is a Canadian-made nattokinase better than an American one?

Not automatically, but the regulatory path differs. Canada requires a product licence and an 8-digit Natural Product Number before a product can be sold, while the US has no pre-market approval requirement. That is a difference in process, not a guarantee of quality in any individual product.

Conclusion

The best brand of nattokinase is whichever one answers all 6 label questions clearly — because the 2,000 FU dose behind a 5.55 mmHg systolic reduction only works if the capsule actually contains and delivers it. Check FU, dose, K2 status, capsule format, batch testing and manufacturing licence before you compare price. If you want a product that states all 6 openly, see BioAbsorb Nattokinase Enzyme.

Research References

1. Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertension Research, Vol. 31, No. 8 (2008). Double-blind trial in 86 adults with untreated systolic pressure of 130–159 mmHg; 2,000 FU daily for 8 weeks produced net reductions of 5.55 mmHg systolic and 2.84 mmHg diastolic versus placebo, with 73 participants completing the protocol.
2. Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reviews in Cardiovascular Medicine, Vol. 24, No. 8 (2023). Pooled 6 randomised trials and 546 participants, rated high methodological quality, finding reductions of 3.45 mmHg systolic and 2.32 mmHg diastolic.
3. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants. Frontiers in Cardiovascular Medicine, Vol. 9 (2022). Retrospective study at 10,800 FU daily over 12 months reporting improved lipid profile and slowed atherosclerosis progression, while challenging the 2,000 FU recommended dose. A corrigendum to this paper was published in December 2022.
4. A single dose of oral nattokinase accelerates skin temperature recovery after cold water immersion: a double-blind, placebo-controlled crossover study. Heliyon, Vol. 9, No. 7 (2023), article e17951. Crossover trial in 9 healthy men; a single 2,000 FU dose accelerated skin temperature recovery after cold water immersion, providing human evidence of a peripheral blood flow effect at the standard dose.
5. Evidence of Reliable Gastro-Resistance of Novel Enteric Ready-to-Fill Capsules Simplifying Pharmaceutical Manufacturing. Pharmaceutics, Vol. 15, No. 11 (2023), article 2592. Establishes the gastro-resistance benchmark of no more than 10% release in acid over at least 2 hours, and the gastric versus intestinal pH contrast.
6. Counterfeit Warning. Japan NattoKinase Association. Sets 2,000 FU as the standard daily dosage requirement and warns that some products carry inflated FU labels or contain no nattokinase at all.
7. JNKA Mark. Japan NattoKinase Association. Confirms that the certification mark requires submission and examination by the association rather than self-declaration.
8. Natural Health Product Licensing Bulletin. Health Canada, Natural and Non-prescription Health Products Directorate. Confirms that all natural health products require a product licence with a Natural Product Number before sale in Canada.
9. What Does a Health Canada Issued "Natural Product Number (NPN)" on a Supplement Mean? McGill University Office for Science and Society. Notes approximately 90,000 licences granted since 2004 and that an NPN can be issued without human clinical trial evidence of efficacy.
10. Nearly half of supplement firms inspected by FDA cited for manufacturing violations. SupplySide Source. FY23 FDA inspection data obtained under FOIA showing close to 33% of Form 483 recipients cited for failing to establish product specifications, and about 18% cited on ingredient identity specifications.
11. Nattokinase Uses, Benefits & Dosage. Drugs.com clinical monograph. Records that nattokinase activity is measured in fibrinolytic units and is inactive in acidic conditions, that microencapsulated and enteric-coated formats were developed to reduce gastric degradation, that vitamin K2 may be removed during manufacturing, and contraindications including ischemic stroke, peptic ulcer, coagulation disorders and surgery.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.